-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Recently, a research article was published in Arthritis & Rheumatology, an authoritative journal in the field of rheumatic immunology , which aims to identify independent risk factors for diastolic dysfunction (DD) in patients with systemic sclerosis (SSc), and to evaluate the effects of DD on the death of SSc patients The impact of the rate
immunity
Researchers performed at least one analyzable 2D echocardiography (2DE) examination on SSc patients who joined the Johns Hopkins Scleroderma Center cohort from January 1, 2006 to November 11, 2017, totaling 806 patients Participant
Researchers prospectively obtained DD risk factors and SSc disease characteristics, and confirmed the presence or absence of DD through a recent 2DE examination
The researchers found that DD was present in 18.
It can be seen that DD is independently related to the increased risk of death in SSc patients
DD is independently associated with an increased risk of death in SSc patients
Original source:
Alicia M.
Diastolic Dysfunction in Systemic Sclerosis: Risk Factors and Impact on Mortality
in this message